These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 25701222)

  • 1. Novel antibiotics: are we still in the pre-post-antibiotic era?
    Draenert R; Seybold U; Grützner E; Bogner JR
    Infection; 2015 Apr; 43(2):145-51. PubMed ID: 25701222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New antibiotics prior to approval: is this the end of the innovative stagnation?].
    Bogner JR
    Internist (Berl); 2014 Dec; 55(12):1486-8, 1490-1. PubMed ID: 25373712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What's new on the antimicrobial horizon?
    Song JH
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic resistance.
    Frieri M; Kumar K; Boutin A
    J Infect Public Health; 2017; 10(4):369-378. PubMed ID: 27616769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview: Global and Local Impact of Antibiotic Resistance.
    Watkins RR; Bonomo RA
    Infect Dis Clin North Am; 2016 Jun; 30(2):313-322. PubMed ID: 27208761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.
    Freire-Moran L; Aronsson B; Manz C; Gyssens IC; So AD; Monnet DL; Cars O;
    Drug Resist Updat; 2011 Apr; 14(2):118-24. PubMed ID: 21435939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions.
    Cox G; Wright GD
    Int J Med Microbiol; 2013 Aug; 303(6-7):287-92. PubMed ID: 23499305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing antimicrobial prescribing.
    Isturiz RE
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S19-22. PubMed ID: 21129628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biofilm-associated infections: antibiotic resistance and novel therapeutic strategies.
    Sun F; Qu F; Ling Y; Mao P; Xia P; Chen H; Zhou D
    Future Microbiol; 2013 Jul; 8(7):877-86. PubMed ID: 23841634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in carbapenems.
    Kattan JN; Villegas MV; Quinn JP
    Clin Microbiol Infect; 2008 Dec; 14(12):1102-11. PubMed ID: 19076841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance.
    Lieberman JM
    Pediatr Infect Dis J; 2003 Dec; 22(12):1143-51. PubMed ID: 14688589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance: how it arises, the current position and strategies for the future.
    Perry C; Hall C
    Nurs Times; 2009 Sep 15-21; 105(36):20-3. PubMed ID: 19835196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-resistant organisms and antibiotic management.
    Barie PS
    Surg Clin North Am; 2012 Apr; 92(2):345-91, ix-x. PubMed ID: 22414417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of antibiotic-resistant pathogens in the community.
    Yagupsky P
    Pediatr Infect Dis J; 2006 Oct; 25(10):974-6. PubMed ID: 17006309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global need for effective antibiotics: challenges and recent advances.
    Högberg LD; Heddini A; Cars O
    Trends Pharmacol Sci; 2010 Nov; 31(11):509-15. PubMed ID: 20843562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview perspective of bacterial resistance.
    Furtado GH; Nicolau DP
    Expert Opin Ther Pat; 2010 Oct; 20(10):1273-6. PubMed ID: 20687782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
    Soo VW; Kwan BW; Quezada H; Castillo-Juárez I; Pérez-Eretza B; García-Contreras SJ; Martínez-Vázquez M; Wood TK; García-Contreras R
    Curr Top Med Chem; 2017; 17(10):1157-1176. PubMed ID: 27697046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial heteroresistance: an emerging field in need of clarity.
    El-Halfawy OM; Valvano MA
    Clin Microbiol Rev; 2015 Jan; 28(1):191-207. PubMed ID: 25567227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical Potential of Synthetic and Natural Pyrrolomycins.
    Cascioferro S; Raimondi MV; Cusimano MG; Raffa D; Maggio B; Daidone G; Schillaci D
    Molecules; 2015 Dec; 20(12):21658-71. PubMed ID: 26690095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.